We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Pandemic Stress Vaccine: A Resource to Enhance the Resilience of Healthcare Workers Facing an Infectious Outbreak

This study has been terminated.
(low participation and retention rates)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00962273
First Posted: August 19, 2009
Last Update Posted: August 19, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Mount Sinai Hospital, Canada
  Purpose
The purpose of this study is to determine the effects of an interactive, computerized learning resource designed to increase resilience in hospital-based health care workers preparing for an influenza pandemic. The effects of the learning resource will be compared to a non-interactive learning resource condition and a control condition. It is hypothesized that (a) online pandemic-related education reduces absenteeism and interpersonal problems for healthcare workers (HCWs), and improves their pandemic self-efficacy in the short and long-term, and (b) an interactive format for online education is necessary for its benefits.

Condition Intervention
Psychological Stress Behavioral: Interactive computerized learning resource Behavioral: Didactic computerized learning resource

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Investigator)
Primary Purpose: Health Services Research
Official Title: The Pandemic Stress Vaccine: Randomized Controlled Trial of an Educational Resource to Enhance the Resilience of Healthcare Workers Facing an Infectious Outbreak

Further study details as provided by Mount Sinai Hospital, Canada:

Primary Outcome Measures:
  • Absenteeism [ Time Frame: 32 weeks ]

Secondary Outcome Measures:
  • Pandemic self-efficacy [ Time Frame: 32 weeks ]
  • Interpersonal problems [ Time Frame: 32 weeks ]

Enrollment: 118
Study Start Date: October 2009
Study Completion Date: July 2010
Primary Completion Date: July 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Pandemic Stress Vaccine - Interactive Behavioral: Interactive computerized learning resource
In a series of interactive scenarios, participants can "see" themselves in stressful work situations that could arise during an influenza pandemic and reflect on effective ways to work out personal and interpersonal difficulties.
Active Comparator: Pandemic Stress Vaccine - Didactic Behavioral: Didactic computerized learning resource
In a non-interactive format (i.e., a series of audio presentations with accompanying PowerPoint-type slides) participants are given information on how to handle stressful work situations that could arise during an influenza pandemic.
No Intervention: Wait list
Some participants are assigned to an eight week waiting condition prior to the course commencing.

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • employee or professional staff of a hospital

Exclusion Criteria:

  • unable to read and write English
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00962273


Locations
Canada, Ontario
Mount Sinai Hospital
Toronto, Ontario, Canada, M5G 1X5
Sponsors and Collaborators
Mount Sinai Hospital, Canada
Investigators
Principal Investigator: William J. Lancee, Ph.D. Mount Sinai Hospital, New York
Principal Investigator: Robert G. Maunder, M.D. Mount Sinai Hospital, New York
  More Information

Publications:
Responsible Party: Dr. William Lancee - Head of Research, Department of Psychiatry, Mount Sinai Hospital
ClinicalTrials.gov Identifier: NCT00962273     History of Changes
Other Study ID Numbers: 09-0133-E
First Submitted: August 18, 2009
First Posted: August 19, 2009
Last Update Posted: August 19, 2010
Last Verified: August 2010

Keywords provided by Mount Sinai Hospital, Canada:
health personnel
communicable diseases
stress, psychological
resilience, psychological
disaster planning
education
online

Additional relevant MeSH terms:
Stress, Psychological
Behavioral Symptoms
Vaccines
Immunologic Factors
Physiological Effects of Drugs